1887

oa South African Family Practice - Medifile : strontium ranelate : the first dual action bone agent

 

Abstract

This edition of Medifile reviews a new drug, strontium ranelate. Protos(r) (strontium ranelate) is the first dual action bone agent registered for the treatment of postmenopausal osteoporosis to reduce the risk of vertebral and peripheral fractures, including the hip.

Loading

Article metrics loading...

/content/mp_safp/48/6/EJC79949
2006-07-01
2016-12-05
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error